Citable company snapshot
Quest Diagnostics's latest SEC-sourced 2026-03-31 period shows $2.90B in revenue and $252.00M in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:RevenueFromContractWithCustomerExcludingAssessedTax | Mar 31, 2026 | $2.90B | $2.81B | +3.2% |
| xbrl:GrossProfit | Dec 31, 2020 | $1.27B | $1.21B | +5.2% |
| xbrl:OperatingIncomeLoss | Mar 31, 2026 | $399.00M | $386.00M | +3.4% |
| xbrl:NetIncomeLoss | Mar 31, 2026 | $252.00M | $245.00M | +2.9% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 31, 2026 | $278.00M | $465.00M | -40.2% |
| Free Cash Flow (computed) | Mar 31, 2026 | $164.00M | $307.00M | -46.6% |
Source: SEC EDGAR XBRL; period Mar 31, 2026; filed Apr 22, 2026; accession 0001022079-26-000043.
Continue research
Follow same-sector companies and source explainers connected to the overview view.
A factual guide to market capitalization, shares outstanding, public float, and why share-count definitions matter.
A factual guide to dividends, share repurchases, and how companies can return capital to shareholders.
A factual guide to book value, tangible book value, and balance-sheet net worth measures.
A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.